Pulmonx (LUNG) Invested Capital (2019 - 2025)

Pulmonx (LUNG) has 7 years of Invested Capital data on file, last reported at $91.0 million in Q4 2025.

• Quarterly Invested Capital fell 25.84% year-over-year to $91.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.0 million (down 25.84% YoY) and the FY2025 annual result came in at $91.0 million, down 25.84% from the prior year.
• Invested Capital retreated to $91.0 million in Q4 2025 per LUNG's latest filing, from $97.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $233.5 million in Q1 2021 and bottomed at $91.0 million in Q4 2025.
• The 5-year median for Invested Capital is $166.9 million (2022), against an average of $162.5 million.
• The widest annual swing landed in 2021, when Invested Capital jumped 220.32%; it then fell 25.92% in 2025.
• Tracing LUNG's Invested Capital over 5 years: stood at $210.1 million in 2021, then retreated by 18.67% to $170.9 million in 2022, then decreased by 9.2% to $155.2 million in 2023, then retreated by 20.92% to $122.7 million in 2024, then retreated by 25.84% to $91.0 million in 2025.
• Per Business Quant, the three latest LUNG Invested Capital figures stand at $91.0 million (Q4 2025), $97.2 million (Q3 2025), and $106.2 million (Q2 2025).

Peer Comparison